PRN: Global Cytogenetics Report 2016-2020 & 2025 - Technologies, Markets and Companies Analysis & Forecasts

Global Cytogenetics Report 2016-2020 & 2025 - Technologies, Markets and Companies Analysis & Forecasts [25-January-2016] DUBLIN, Jan. 25, 2016 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/pbpgpn/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering.

Persone Laura Wood, Molecular Detection
Luoghi Italia, Europa, Giappone, Germania, Francia, Spagna, Dublino, Regno Unito, Western Division
Organizzazioni FISH technologies, Forecasts
Argomenti impresa, software, economia, internet

25/gen/2016 19.10.54 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Cytogenetics Report 2016-2020 & 2025 - Technologies, Markets and Companies Analysis & Forecasts

 
[25-January-2016]
 

DUBLIN, Jan. 25, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/pbpgpn/cytogenetics) has announced the addition of Jain PharmaBiotech's new report "Cytogenetics - Technologies, Markets and Companies" to their offering.

The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH. Molecular cytogenetics includes application of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection. Bioinformatics is described briefly as it plays an important role in analyzing data from many of these technologies.

Technologies encompassed within molecular imaging include optical imaging, magnetic resonance imaging (MRI) and nuclear medicine techniques. Positron emission tomography (PET) is the most sensitive and specific technique for imaging molecular pathways in vivo in humans. Cytogenetics can be refined by application of cytogenetics at single molecule level. Nanotechnology has facilitated the development of technology for single molecule imaging. Atomic force microscope (AFM) has become a well-established technique for imaging single biomolecules under physiological conditions. The scanning probe microscope (SPM) system is emerging as an increasingly important tool for non-intrusive interrogation of biomolecular systems in vitro and have been applied to improve FISH. Another example of application of nanobiotechnology is QD (quantum dot)-FISH probes, which can detect down to the single molecule level.

The chapter on markets provides a global perspective of the cytogenetics business in the major markets: US, Western Europe (including France, Germany, Italy, Spain, and the UK), and Japan. The total figures for the market are also broken out according to the technologies and major disease areas in which they are applied. Markets figure are given for the year 2015 and estimates are made for the years 2020 and 2025. Advantages and limitations of various technologies have been pointed out throughout the report but this chapter includes SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis of some of the competing technologies including the following: conventional FISH, innovative FISH technologies, PCR-based assays, and single molecule imaging. Unfulfilled needs in cyto! genetics market are depicted graphically. Among various technologies, FISH is most advanced and less opportunities for further development than single molecule detection, which is in infancy and has more future potential.

The report includes summary profiles of 69 companies relevant to cytogenetics along with their 79 collaborations. Companies developing innovative technologies as well as those supplying equipment/services/reagents are identified.The report text is supplemented with 27 Tables and 9 figures. Selected 200 references are included in the bibliography.

Key Topics Covered:

Executive Summary

1. Introduction

2. Technologies used for cytogenetics

3. Fluorescent In Situ Hybridization

4. Genomic Technologies relevant to Cytogenetics

5. Molecular Imaging & Single Molecular Detection

6. Role of Nanobiotechnology in Cytogenetics

7. Biomarkers and Cytogenetics

8. Applications of Cytogenetics

9. Cancer Cytogenetics

10. Cytogenetics Markets

11. Companies

12. References

For more information visit

http://www.researchandmarkets.com/research/pbpgpn/cytogenetics

Source: Jain PharmaBiotech

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl